0001601983-16-000002.txt : 20160909
0001601983-16-000002.hdr.sgml : 20160909
20160909131456
ACCESSION NUMBER: 0001601983-16-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160909
DATE AS OF CHANGE: 20160909
EFFECTIVENESS DATE: 20160909
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHRONO THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001601983
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-270385
FILM NUMBER: 161878472
BUSINESS ADDRESS:
STREET 1: 3953 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 362-7823
MAIL ADDRESS:
STREET 1: 3953 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
D
1
primary_doc.xml
X0707
D
LIVE
0001601983
CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
(510) 362-7823
CALIFORNIA
DiPierro Ventures, Inc.
None
Corporation
true
ALAN
LEVY, PH.D.
C/O CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
Executive Officer
Director
ANTHONY
RIMAC
C/O CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
Executive Officer
JAMES
W.
YOUNG
C/O CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
Director
WENDE
HUTTON
C/O CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
Director
TIM
KILGALLON
C/O CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
Director
GUY
DIPIERRO
C/O CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
Director
AIDAN
KING
C/O CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
Director
STEVEN
JAMES
C/O CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
Director
ELIZABETH
ROCKETT
C/O CHRONO THERAPEUTICS INC.
3953 POINT EDEN WAY
HAYWARD
CA
CALIFORNIA
94545
Director
Other Health Care
Decline to Disclose
- 06b
false
2016-08-26
false
true
false
0
47607004
37606945
10000059
Shares of Series B Preferred Stock and shares of Common Stock issuable upon conversion of the shares of Series B Preferred Stock.
false
22
0
true
0
true
0
true
false
CHRONO THERAPEUTICS INC.
/s/ Anthony M. Rimac
ANTHONY M. RIMAC
CHIEF FINANCIAL OFFICER
2016-09-09